RxDoctor Payments Data

Kimberly Estes, MD

Family Medicine · Meadville, MSNPI 1790911303

Payments from drug & device makers

$681in general payments, 2019–2025

Across 44 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$130
  • Boehringer Ingelheim$127
  • Novo Nordisk$95
  • AstraZeneca$90
  • Pfizer$60
  • AbbVie$55
  • plus $126 from 5 others

What the payments were for

  • Food & beverage$681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$681 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$9,746
Medicare patients
47
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EnbrelEtanercept12$176,268
EliquisApixaban250$61,566
JardianceEmpagliflozin148$31,669
XareltoRivaroxaban162$27,478
EntrestoSacubitril/Valsartan84$25,765
LinzessLinaclotide27$23,092
OzempicSemaglutide18$19,065
FarxigaDapagliflozin Propanediol52$18,281
TradjentaLinagliptin14$13,926
NamzaricMemantine Hcl/Donepezil Hcl76$12,043
VyvanseLisdexamfetamine Dimesylate14$10,420
Potassium Chloride625$10,342
Breo ElliptaFluticasone/Vilanterol20$8,337
Tresiba Flextouch U-100Insulin Degludec15$7,342
JanumetSitagliptin Phos/Metformin Hcl50$7,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$60$61,566250 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$127$52,201176 claims
AbbVieLinzess, Namzaric$55$35,135103 claims
NovartisEntresto$37$25,76584 claims
Novo NordiskOzempic, Tresiba$95$25,45332 claims
AstraZenecaFarxiga, Lokelma$90$24,80966 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$29$10,42014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Meadville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →